- Home
- FTRE vs CAPL Comparison
FTRE vs CAPL Comparison
Compare FTRE & CAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- CAPL
- Stock Information
- Founded
- FTRE 1996
- CAPL 1992
- Country
- FTRE United States
- CAPL United States
- Employees
- FTRE N/A
- CAPL N/A
- Industry
- FTRE Medical Specialities
- CAPL Oil Refining/Marketing
- Sector
- FTRE Health Care
- CAPL Energy
- Exchange
- FTRE Nasdaq
- CAPL Nasdaq
- Market Cap
- FTRE 864.4M
- CAPL 800.9M
- IPO Year
- FTRE N/A
- CAPL 2012
- Fundamental
- Price
- FTRE $9.40
- CAPL $20.05
- Analyst Decision
- FTRE Hold
- CAPL
- Analyst Count
- FTRE 9
- CAPL 0
- Target Price
- FTRE $12.06
- CAPL N/A
- AVG Volume (30 Days)
- FTRE 1.5M
- CAPL 29.5K
- Earning Date
- FTRE 11-07-2025
- CAPL 11-05-2025
- Dividend Yield
- FTRE N/A
- CAPL 10.45%
- EPS Growth
- FTRE N/A
- CAPL 100.77
- EPS
- FTRE N/A
- CAPL 1.13
- Revenue
- FTRE $2,733,500,000.00
- CAPL $3,522,840,000.00
- Revenue This Year
- FTRE N/A
- CAPL N/A
- Revenue Next Year
- FTRE N/A
- CAPL N/A
- P/E Ratio
- FTRE N/A
- CAPL $17.84
- Revenue Growth
- FTRE N/A
- CAPL N/A
- 52 Week Low
- FTRE $3.97
- CAPL $19.50
- 52 Week High
- FTRE $25.28
- CAPL $25.73
- Technical
- Relative Strength Index (RSI)
- FTRE 53.01
- CAPL 36.18
- Support Level
- FTRE $9.25
- CAPL $20.20
- Resistance Level
- FTRE $9.89
- CAPL $21.13
- Average True Range (ATR)
- FTRE 0.57
- CAPL 0.43
- MACD
- FTRE -0.12
- CAPL -0.12
- Stochastic Oscillator
- FTRE 45.93
- CAPL 5.41
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.